Concert Pharma Names Ex-Merrimack Exec Munsie Chief Legal Officer

Xconomy Boston — 

Concert Pharmaceuticals (NASDAQ: CNCE) has appointed Jeffrey Munsie to serve as its chief legal officer. Munsie was most recently senior vice president, general counsel, and head of corporate operations at Merrimack Pharmaceuticals (NASDAQ: MACK). Earlier this month, Lexington, MA-based Concert released positive Phase 2 data for CTP-543, an experimental treatment for hair loss caused by alopecia areata.